Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201212078 Principal Investigator: Lockhart, A. Craig
Title: Randomized, Open Label, Phase 2 Study of MM-111 and Paclitaxel with or without Trastuzumab in Patients with ‘Traditional’ and ‘Non-Traditional’ HER2 Expressing Carcinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and Stomach Who Have Failed Front Line Metastatic or Locally Advanced Therapy
Phase: II Disease Site: Multiple Sites
Participating Site(s):
 
Main Campus
Map and Directions
South County
Map and Directions
St. Peters
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this study is to evaluate how well MM-111 controls esophageal, gastroesophageal, or gastric cancer that expresses a protein called HER2 when given in combination with standard treatment (paclitaxel and trastuzumab).
 
More Information:
clinicaltrials.gov link
Internal Protocol Documents (requires Siteman administrative database password)